US Stock MarketDetailed Quotes

Black Diamond Therapeutics (BDTX)

Watchlist
  • 2.650
  • +0.080+3.11%
Close Jan 22 16:00 ET
150.98MMarket Cap7.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Black Diamond Therapeutics (BDTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.67%-7.85M
37.80%-9.16M
351.95%53.41M
6.62%-62.3M
-7.87%-15.06M
38.33%-11.32M
-2.49%-14.73M
-5.83%-21.2M
21.59%-66.72M
36.39%-13.96M
Net income from continuing operations
45.38%-8.5M
46.95%-10.56M
410.24%56.54M
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
Operating gains losses
97.92%-1K
---13K
---13K
-126.26%-94K
---8K
-114.95%-48K
----
----
2,005.88%358K
--0
Depreciation and amortization
0.00%86K
0.00%86K
1.16%87K
-21.51%343K
-1.16%85K
-25.22%86K
-24.56%86K
-29.51%86K
-13.98%437K
-31.75%86K
Other non cash items
5.75%791K
5.83%780K
5.63%769K
5.58%2.97M
5.57%758K
5.65%748K
5.59%737K
5.51%728K
3.08%2.81M
5.43%718K
Change In working capital
-167.65%-1.68M
-470.97%-805K
-15.12%-5.26M
-173.03%-2.69M
-120.79%-816K
99.52%2.48M
-83.37%217K
-64.06%-4.57M
137.23%3.69M
184.17%3.93M
-Change in prepaid assets
-48.76%475K
159.66%105K
30.32%-678K
-98.54%33K
60.38%255K
37.95%927K
-116.75%-176K
-354.05%-973K
122.50%2.27M
-91.62%159K
-Change in payables and accrued expense
-153.37%-1.26M
-102.68%-42K
-34.42%-3.73M
-79.56%927K
-104.96%-227K
74.63%2.36M
53.88%1.57M
-14.83%-2.77M
156.03%4.54M
178.72%4.58M
-Change in other current assets
0.00%44K
113.06%44K
--44K
---249K
--44K
--44K
---337K
--0
--0
--0
-Change in other current liabilities
-9.11%-934K
-9.22%-912K
-9.22%-900K
-9.28%-3.4M
-9.09%-888K
-9.32%-856K
-9.44%-835K
-9.28%-824K
-9.61%-3.11M
-9.56%-814K
Cash from discontinued investing activities
Operating cash flow
30.67%-7.85M
37.80%-9.16M
351.95%53.41M
6.62%-62.3M
-7.87%-15.06M
38.33%-11.32M
-2.49%-14.73M
-5.83%-21.2M
21.59%-66.72M
36.39%-13.96M
Investing cash flow
Cash flow from continuing investing activities
291.70%8.59M
-8,093.65%-59.15M
162.23%8.55M
3.81%16.97M
126.70%27.77M
105.79%2.19M
-95.69%740K
-155.37%-13.73M
-69.37%16.35M
427.52%12.25M
Net PPE purchase and sale
-97.92%1K
-73.68%10K
--13K
51.61%94K
--8K
245.45%48K
--38K
--0
133.88%62K
--0
Net investment purchase and sale
300.42%8.59M
-8,527.78%-59.16M
162.14%8.53M
3.62%16.87M
126.64%27.76M
105.67%2.15M
-95.89%702K
-155.37%-13.73M
-69.59%16.28M
429.57%12.25M
Cash from discontinued investing activities
Investing cash flow
291.70%8.59M
-8,093.65%-59.15M
162.23%8.55M
3.81%16.97M
126.70%27.77M
105.79%2.19M
-95.69%740K
-155.37%-13.73M
-69.37%16.35M
427.52%12.25M
Financing cash flow
Cash flow from continuing financing activities
153.17%134K
-100.54%-116K
-99.23%32K
-64.48%25.55M
732.61%291K
-100.35%-252K
21.38M
7,998.04%4.13M
40,539.55%71.93M
-64.29%-46K
Net common stock issuance
--0
--0
--0
-65.91%24.49M
--0
-100.70%-500K
--21.01M
--3.98M
--71.85M
--0
Proceeds from stock option exercised by employees
-45.97%134K
-131.87%-116K
-78.67%32K
1,184.15%1.05M
732.61%291K
222.08%248K
--364K
194.12%150K
-53.67%82K
-64.29%-46K
Cash from discontinued financing activities
Financing cash flow
153.17%134K
-100.54%-116K
-99.23%32K
-64.48%25.55M
732.61%291K
-100.35%-252K
--21.38M
7,998.04%4.13M
40,539.55%71.93M
-64.29%-46K
Net cash flow
Beginning cash position
-8.37%30.82M
278.21%99.25M
-34.69%37.26M
60.76%57.04M
-58.75%24.25M
-21.99%33.63M
-34.90%26.24M
60.76%57.04M
-47.06%35.48M
6.66%58.8M
Current changes in cash
109.32%874K
-1,025.70%-68.43M
301.24%61.99M
-191.78%-19.79M
841.87%13.01M
-159.83%-9.38M
163.34%7.39M
-738.27%-30.8M
168.36%21.56M
91.08%-1.75M
End cash Position
30.68%31.69M
-8.37%30.82M
278.21%99.25M
-34.69%37.26M
-34.69%37.26M
-58.75%24.25M
-21.99%33.63M
-34.90%26.24M
60.76%57.04M
60.76%57.04M
Free cash flow
30.67%-7.85M
37.80%-9.16M
351.95%53.41M
6.66%-62.3M
-7.87%-15.06M
38.45%-11.32M
-2.49%-14.73M
-5.83%-21.2M
21.72%-66.75M
36.39%-13.96M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.67%-7.85M37.80%-9.16M351.95%53.41M6.62%-62.3M-7.87%-15.06M38.33%-11.32M-2.49%-14.73M-5.83%-21.2M21.59%-66.72M36.39%-13.96M
Net income from continuing operations 45.38%-8.5M46.95%-10.56M410.24%56.54M15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M
Operating gains losses 97.92%-1K---13K---13K-126.26%-94K---8K-114.95%-48K--------2,005.88%358K--0
Depreciation and amortization 0.00%86K0.00%86K1.16%87K-21.51%343K-1.16%85K-25.22%86K-24.56%86K-29.51%86K-13.98%437K-31.75%86K
Other non cash items 5.75%791K5.83%780K5.63%769K5.58%2.97M5.57%758K5.65%748K5.59%737K5.51%728K3.08%2.81M5.43%718K
Change In working capital -167.65%-1.68M-470.97%-805K-15.12%-5.26M-173.03%-2.69M-120.79%-816K99.52%2.48M-83.37%217K-64.06%-4.57M137.23%3.69M184.17%3.93M
-Change in prepaid assets -48.76%475K159.66%105K30.32%-678K-98.54%33K60.38%255K37.95%927K-116.75%-176K-354.05%-973K122.50%2.27M-91.62%159K
-Change in payables and accrued expense -153.37%-1.26M-102.68%-42K-34.42%-3.73M-79.56%927K-104.96%-227K74.63%2.36M53.88%1.57M-14.83%-2.77M156.03%4.54M178.72%4.58M
-Change in other current assets 0.00%44K113.06%44K--44K---249K--44K--44K---337K--0--0--0
-Change in other current liabilities -9.11%-934K-9.22%-912K-9.22%-900K-9.28%-3.4M-9.09%-888K-9.32%-856K-9.44%-835K-9.28%-824K-9.61%-3.11M-9.56%-814K
Cash from discontinued investing activities
Operating cash flow 30.67%-7.85M37.80%-9.16M351.95%53.41M6.62%-62.3M-7.87%-15.06M38.33%-11.32M-2.49%-14.73M-5.83%-21.2M21.59%-66.72M36.39%-13.96M
Investing cash flow
Cash flow from continuing investing activities 291.70%8.59M-8,093.65%-59.15M162.23%8.55M3.81%16.97M126.70%27.77M105.79%2.19M-95.69%740K-155.37%-13.73M-69.37%16.35M427.52%12.25M
Net PPE purchase and sale -97.92%1K-73.68%10K--13K51.61%94K--8K245.45%48K--38K--0133.88%62K--0
Net investment purchase and sale 300.42%8.59M-8,527.78%-59.16M162.14%8.53M3.62%16.87M126.64%27.76M105.67%2.15M-95.89%702K-155.37%-13.73M-69.59%16.28M429.57%12.25M
Cash from discontinued investing activities
Investing cash flow 291.70%8.59M-8,093.65%-59.15M162.23%8.55M3.81%16.97M126.70%27.77M105.79%2.19M-95.69%740K-155.37%-13.73M-69.37%16.35M427.52%12.25M
Financing cash flow
Cash flow from continuing financing activities 153.17%134K-100.54%-116K-99.23%32K-64.48%25.55M732.61%291K-100.35%-252K21.38M7,998.04%4.13M40,539.55%71.93M-64.29%-46K
Net common stock issuance --0--0--0-65.91%24.49M--0-100.70%-500K--21.01M--3.98M--71.85M--0
Proceeds from stock option exercised by employees -45.97%134K-131.87%-116K-78.67%32K1,184.15%1.05M732.61%291K222.08%248K--364K194.12%150K-53.67%82K-64.29%-46K
Cash from discontinued financing activities
Financing cash flow 153.17%134K-100.54%-116K-99.23%32K-64.48%25.55M732.61%291K-100.35%-252K--21.38M7,998.04%4.13M40,539.55%71.93M-64.29%-46K
Net cash flow
Beginning cash position -8.37%30.82M278.21%99.25M-34.69%37.26M60.76%57.04M-58.75%24.25M-21.99%33.63M-34.90%26.24M60.76%57.04M-47.06%35.48M6.66%58.8M
Current changes in cash 109.32%874K-1,025.70%-68.43M301.24%61.99M-191.78%-19.79M841.87%13.01M-159.83%-9.38M163.34%7.39M-738.27%-30.8M168.36%21.56M91.08%-1.75M
End cash Position 30.68%31.69M-8.37%30.82M278.21%99.25M-34.69%37.26M-34.69%37.26M-58.75%24.25M-21.99%33.63M-34.90%26.24M60.76%57.04M60.76%57.04M
Free cash flow 30.67%-7.85M37.80%-9.16M351.95%53.41M6.66%-62.3M-7.87%-15.06M38.45%-11.32M-2.49%-14.73M-5.83%-21.2M21.72%-66.75M36.39%-13.96M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -